Received Aug 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
administration of a Priorix dose no longer stable after a temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a female patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced incorrect storage of drug (Verbatim: administration of a Priorix dose no longer stable after a temperature excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 24-JUL-2025 The office manager called to get stability information of Priorix exposed to minus18°F as the minimum for 30 days which led to, incorrect storage of drug. No prior excursions. After giving the stability info, she asked how to proceed if she administered one of the doses exposed to the excursion to a patient. The information was shared. The agent tried to collect the adverse event details, but she mentioned to have no access at the time, so the agent provided the case number for a call back from her to provide the details. The caller only confirmed the zip code of the facility where the vaccine was given, for the rest she mentioned to have no access at the time of the call, so would try to call us back to provide was needed (case number was given to her for so). The Vaccine Administration Facility was the same as Primary Reporter.